8:30am - 5:00pm

Our Office Hours Mon. - Fri.


or 1-800-446-5879 | Local 727-849-5353




Bad Drug Marketing Costs Johnson & Johnson $2.2 Billion!

Lucas|Magazine > Defective Products  > Bad Drug Marketing Costs Johnson & Johnson $2.2 Billion!

Bad Drug Marketing Costs Johnson & Johnson $2.2 Billion!

Irresponsible Drug Marketing is COSTLY!

The Law Offices of Lucas | Magazine Comments on Recent Johnson & Johnson Settlement

Health care manufacturer Johnson and Johnson will be paying $2.2 BILLION to resolve criminal and civil fees over allegations that they marketed three drugs for uses that were not approved.    Check out the stories by visiting the links below.

J.&J. to Pay $2.2 Billion in Risperdal Settlement – NYTimes.com

3 days ago … Federal officials said Johnson & Johnson promoted the antipsychotic drug as a way to treat dementia patients for many ailments, when it was …read more

Johnson & Johnson to pay $2.2B in US health care fraud settlement
3 days ago … Allegations include paying kickbacks to physicians, pharmacies to recommend and prescribe antipsychotic drugs Risperdal and Invega…  read more


Check out what our legal team has to say on the topic …

Learn More about Jim Magazine

Attorney Jim Magazine:  

“This is typical big business profits over people they are marketing the drugs for non intended purposes for profit-  At the expense of people.  This is the perfect example on why it is so important NOT TO HAVE TORT REFORM.    The fines were too small!   I would  bet the profits from the non intended sales far out weigh the fines”

Conde small New Port Richey Injury Lawyers

Attorney Clementine Conde: 

“The recent settlement reached between Drug manufacturer JOHNSON & JOHNSON and its subsidiaries and U.S. Attorney’s office  to pay $2.2 billion  highlights  the abuse by these companies on our Country’s most vulnerable citizens. This week JOHNSON & JOHNSON agreed to the settlements to cover claims  that they marketed three drugs that were never approved by the Food and Drug Administration.  Drugs such as Risperdal , which is a powerful drug used for schizophrenia  was marketed to elderly people  to treat dementia. Said drugs were administered to non-schizophrenic patients  in nursing homes and assisted living facilities. This is not only  reprehensible from a moral standpoint but it is criminal as well. Companies like JOHNSON&JOHNSON make billions of dollars manufacturing drugs that –do help individuals lead better lives. The fact that they would market a drug to a group of individuals that do not need said drugs is an example of corporate greed. These companies need to be held accountable for their decisions by not only paying a fine, but with their  freedom. Their actions in marketing drugs that harm the elderly and mentally ill is no different than poisoning the water they drink.  While I applaud US Attorney, Eric Holder for pursuing said company, more needs to be done to ensure that our citizens are protected.”